Evidence map›Paper›PMID 40650250›Full record

ReviewInternational journal of molecular sciences2025

The Role of Selected Proteins in the Pathogenesis of Psoriasis.

Mateusz Matwiejuk, Agnieszka Kulczyńska-Przybik, Hanna Myśliwiec, Adrian Chabowski, Barbara Mroczko, Iwona Flisiak

Abstract readReview
In one paragraph

Review in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Mateusz MatwiejukDepartment of Dermatology and Venereology, Medical University of Bialystok, 15-540 Bialystok, Poland.ORCID 0000-0002-2873-4001
Agnieszka Kulczyńska-PrzybikDepartment of Neurodegeneration Diagnostics, Medical University of Bialystok, 15-269 Bialystok, Poland.
Hanna MyśliwiecDepartment of Dermatology and Venereology, Medical University of Bialystok, 15-540 Bialystok, Poland.ORCID 0000-0003-1948-0545
Adrian ChabowskiDepartment of Physiology, Medical University of Bialystok, 15-222 Bialystok, Poland.ORCID 0000-0002-7407-8156
Barbara MroczkoDepartment of Neurodegeneration Diagnostics, Medical University of Bialystok, 15-269 Bialystok, Poland.ORCID 0000-0002-4075-8479
Iwona FlisiakDepartment of Dermatology and Venereology, Medical University of Bialystok, 15-540 Bialystok, Poland.ORCID 0000-0002-5923-910X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Psoriasis is a chronic, immune-mediated inflammatory skin disease with complex genetic, environmental, and immunological determinants. Beyond the skin, it affects multiple systems, including the joints and cardiovascular system. A hallmark of psoriasis is an overactivation of the innate and adaptive immune responses, leading to dysregulated cytokine signaling, altered keratinocyte function, and aberrant expression of structural and regulatory proteins. In recent years, growing attention has been given to the skin as a neuro-immuno-endocrine organ, with evidence showing the role of stress-related neuropeptides, UVB-induced immune modulation, and vitamin D signaling in the disease pathogenesis. This review highlights emerging evidence on key multifunctional proteins-elafin, chemerin, and NAMPT (visfatin)-that exert both pro- and anti-inflammatory actions. Although still underexplored, these molecules appear to contribute significantly to the psoriatic microenvironment by modulating inflammation, immunity, and skin barrier function. Their dual roles suggest complex interactions within the cutaneous immune-neuroendocrine network, positioning them as potential biomarkers or therapeutic targets in psoriasis. By integrating insights into classical and emerging mediators, this review aims to provide a comprehensive perspective on the evolving landscape of psoriasis pathophysiology.

Indexed as

PsoriasisAnimalsChemokinesCytokinesHumansIntercellular Signaling Peptides and ProteinsNicotinamide PhosphoribosyltransferaseSkinChemokinesCytokinesIntercellular Signaling Peptides and ProteinsNicotinamide PhosphoribosyltransferaseRARRES2 protein, humanchemerinelafinnicotinamide phosphoribosyltransferasepsoriasisvisfatin

Identifiers

PMID40650250
PMCPMC12250344

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.